|
市場調査レポート
商品コード
1566181
心臓構造デバイスの市場規模、シェア、成長分析、製品別、手技別、地域別 - 産業予測、2024年～2031年Structural Heart Devices Market Size, Share, Growth Analysis, By Product, By Procedure, By Region - Industry Forecast 2024-2031 |
||||||
|
|||||||
| 心臓構造デバイスの市場規模、シェア、成長分析、製品別、手技別、地域別 - 産業予測、2024年～2031年 |
|
出版日: 2024年10月03日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
心臓構造デバイス市場規模は2022年に109億7,000万米ドル、予測期間（2024-2031年）のCAGRは9.4%で、2023年の119億7,000万米ドルから2031年には245億8,000万米ドルに成長する見通し
世界の心臓構造デバイス市場は、構造的な心臓疾患の発生率の上昇、低侵襲手術技術の進歩、高齢化層の拡大など、いくつかの重要な要因によって力強い成長を遂げています。心血管疾患の有病率が上昇するにつれ、心臓構造デバイスの需要は増加の一途をたどり、革新的な治療オプションの採用をさらに後押ししています。同市場は、技術的に先進的な機器への強い後押しと研究開発への多額の投資によって支えられており、この分野における技術革新の重要性を浮き彫りにしています。しかし、これらの機器の高額なコストや厳しい規制のハードルといった課題は、成長の妨げになる可能性があります。このような障害にもかかわらず、心臓構造治療機器技術の絶え間ない進歩と循環器内科における患者中心の治療への関心の高まりに支えられ、市場は上昇基調を維持すると予想されます。特に、米国の心臓構造デバイス市場は持続的な成長が期待できる位置にあり、今後の予測期間においても安定した年間平均成長率（CAGR）が見込まれています。この動向は、構造的な心臓病の領域における治療オプションの強化と最先端技術のソリューションを通じて、患者の転帰を改善するというヘルスケア業界のコミットメントを強調するものです。
目次
イントロダクション
- 調査の目的
- 定義
- 市場範囲
調査手法
- 情報調達
- 二次データソースと一次データソース
- 市場規模予測
- 市場の想定と制限
エグゼクティブサマリー
- 市場概要見通し
- 供給需要動向分析
- セグメント別機会分析
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- ポーターの分析
主な市場の考察
- 主な成功要因
- 競合の程度
- 主な投資機会
- 市場のエコシステム
- 規制分析
- ケーススタディ分析
- 市場の魅力指数
- サプライチェーン分析
- 顧客と購買基準の分析
心臓構造デバイス市場：製品別
- 市場概要
- 心臓弁デバイス
- 経カテーテル心臓弁
- 外科用心臓弁
- 組織心臓弁
- 人工心臓弁
- 閉塞器具とデリバリーシステム
- 環状形成リング
- アクセサリー
- その他のデバイス
心臓構造デバイス市場：手技別
- 置換術
- Tavr術
- Savr術
- 修復術
- 閉鎖術
- 輪状形成術
- 弁形成術
- TMVr術
心臓構造デバイス市場規模：地域別
- 市場概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
- アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
- ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
- 中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2023年）
- 主な市場企業が採用した戦略
- 市場における最近の活動
- 主要企業の市場シェア（2023年）
主要企業プロファイル
- Boston Scientific Corporation
- Medtronic
- Edwards Lifesciences Corporation
- Abbott Laboratories
- Biomerics
- Teleflex Incorporated
- LivaNova PLC
- JenaValve Technology, Inc.
- CardioKinetix
- Lepu Medical Technology
- CryoLife
- Micro Interventional Devices
- Braile Biomedica
- TTK Healthcare（A TTK Group Company）
Structural Heart Devices Market size was valued at USD 10.97 billion in 2022 and is poised to grow from USD 11.97 billion in 2023 to USD 24.58 billion by 2031, growing at a CAGR of 9.4% in the forecast period (2024-2031)
The global structural heart devices market is experiencing robust growth, fueled by several key factors, including the rising incidence of structural heart diseases, advancements in minimally invasive surgical techniques, and an expanding aging demographic. As the prevalence of cardiovascular conditions escalates, the demand for structural heart devices continues to increase, further driving the adoption of innovative treatment options. The market is bolstered by a strong push for technologically advanced devices and significant investments in research and development, highlighting the importance of innovation in this sector. However, challenges such as the high costs of these devices and strict regulatory hurdles could hinder growth. Despite these obstacles, the market is anticipated to maintain its upward trajectory, supported by continuous advancements in structural heart device technology and a heightened focus on patient-centered care within cardiology. In particular, the U.S. structural heart devices market is well-positioned for sustainable growth, with expectations for a steady compound annual growth rate (CAGR) in the upcoming forecast period. This trend underscores the healthcare industry's commitment to improving patient outcomes through enhanced treatment options and cutting-edge technological solutions in the realm of structural heart diseases.
Top-down and bottom-up approaches were used to estimate and validate the size of the Structural Heart Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Structural Heart Devices Market Segmental Analysis
Global Structural Heart Devices Market is segmented by Product, Procedure, and region. Based on Product, the market is segmented into Heart Valve Devices (Transcatheter Heart Valves, Surgical Heart Valves (Tissue Heart Valves, Mechanical Heart Valves)), Occluders & Delivery Systems, Annuloplasty Rings, Accessories, and Other Devices. Based on Procedure, the market is segmented into Replacement Procedures (TAVR Procedures, Savr Procedures), Repair Procedures (Closure Procedures, Annuloplasty, Valvuloplasty, TMVR Procedures). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.
Driver of the Structural Heart Devices Market
The global structural heart devices market is significantly driven by the rising prevalence of structural heart diseases, including heart valve disorders and congenital abnormalities, which necessitate advanced treatment options. As the incidence of these conditions escalates, the demand for specialized devices has surged. Furthermore, technological advancements in minimally invasive procedures have enhanced patient outcomes, making treatments more accessible and effective. Coupled with the increasing geriatric population, which is particularly vulnerable to these ailments, the market continues to expand. This growing demographic shift and innovation in medical devices create a robust environment for the structural heart devices market's growth and evolution.
Restraints in the Structural Heart Devices Market
The global structural heart devices market faces a significant restraint due to the high costs associated with these advanced medical devices and their implantation procedures. The expense encompasses not only the devices themselves but also the comprehensive costs of development, clinical trials, and adherence to regulatory standards, which can place a financial strain on both patients and healthcare systems. In particular, developing regions may experience limited accessibility and affordability, further curtailing market penetration. Additionally, price sensitivity among consumers and restricted insurance coverage in certain markets can impede the widespread adoption of structural heart devices, ultimately stunting the overall growth of the market.
Market Trends of the Structural Heart Devices Market
A prominent trend in the global structural heart devices market is the surge in minimally invasive procedures, exemplified by transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve repair (TMVR). These innovative techniques are increasingly favored for their substantial advantages, including shorter hospital stays, expedited recovery times, and diminished complications compared to conventional open-heart surgeries. This growth is propelled by continuous advancements in medical technology that enhance procedural precision and efficacy. As healthcare providers and patients alike recognize the benefits of these less invasive options, the demand for structural heart devices is expected to rise steadily, shaping the market's future landscape.
Table of Contents
Introduction
- Objectives of the Study
- Definitions
- Market Scope
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Executive Summary
- Market Overview Outlook
- Supply Demand Trend Analysis
- Segmental Opportunity Analysis
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factor
- Degree of Competition
- Top Investment Pockets
- Ecosystem of the Market
- Regulatory Analysis
- Case Study Analysis
- Market Attractiveness Index
- Supply Chain Analysis
- Customer & Buying Criteria Analysis
Structural Heart Devices Market, By Product
- Market Overview
- Heart Valve Devices
- Transcatheter Heart Valves
- Surgical Heart Valves
- Tissue Heart Valves
- Mechanical Heart Valves
- Occluders & Delivery Systems
- Annuloplasty Rings
- Accessories
- Other Devices
Structural Heart Devices Market, By Procedure
- Replacement Procedures
- Tavr Procedures
- Savr Procedures
- Repair Procedures
- Closure Procedures
- Annuloplasty
- Valvuloplasty
- Tmvr Procedures
Structural Heart Devices Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2023
- Strategies Adopted by Key Market Players
- Recent Activities in the Market
- Key Companies Market Share (%), 2023
Key Company Profiles
- Boston Scientific Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medtronic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Edwards Lifesciences Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Biomerics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Teleflex Incorporated
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- LivaNova PLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- JenaValve Technology, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CardioKinetix
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Lepu Medical Technology
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CryoLife
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Micro Interventional Devices
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Braile Biomedica
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- TTK Healthcare (A TTK Group Company)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
